Literature DB >> 962409

Pulmonary venoocclusive disease.

S K Chawla, C F Kittle, L P Faber, R J Jensik.   

Abstract

Pulmonary venoocclusive disease has been established as a definite clinical entity characterized by congestive cardiac failure with pulmonary arterial hypertension, chronic interstitial pulmonary edema, and normal wedge pressure on cardiac catheterization. This disease was diagnosed and confirmed in a patient during life. A review of the 32 patients reported earlier has been done in an attempt to fine possible etiological agents. Early recognition and treatment with anticoagulants, methylprednisolone, aspirin, and dipyridamole may improve the prognosis.

Entities:  

Mesh:

Year:  1976        PMID: 962409     DOI: 10.1016/s0003-4975(10)64911-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Severe pulmonary artery hypertension.

Authors:  A Roglan; A Artigas; J Solé
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings.

Authors:  V S Rambihar; E L Fallen; J A Cairns
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

4.  Congenital unilateral pulmonary venous atresia with pulmonary veno-occlusive disease in contralateral lung: an unusual association.

Authors:  S Shrivastava; J H Moller; J E Edwards
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.